Gastric 2023

4 papers
The 2023 edition of Gastric focused on molecular profiling and computational pathology to enhance precision prognosis and treatment response. Research themes emphasized transcriptomic and proteomic analysis, particularly in identifying signatures associated with the immune microenvironment and peritoneal metastasis. Notable studies investigated the mutational landscape of primary gastric linitis plastica and the role of SPRY4 in sensitizing gastrointestinal stromal tumors to imatinib. These works reflect a broader trend toward using weighted gene co-expression networks and microRNA-mediated regulation to map functional disease modules. A significant portion of the year’s contributions integrated deep learning for objective tissue analysis. This included the use of attention-based multiple instance learning for histological subtyping and the inference of immune infiltration from bulk transcriptomic data. Researchers such as Jing Han, Jinsen Zheng, and Jiuli Wang contributed to advancing subtype-specific stratification and bridging granularity gaps in registry-based survival models. Collectively, these efforts aimed to refine cancer risk stratification through multimodal biomarkers and signal-induced feedback mechanisms, providing more robust frameworks for clinical outcome prediction.

Top Research Directions

The 10 research directions with Gastric 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Attention Based Multiple Instance Learning1025.0%0.0%—
2Decoding Sub-Visual Textures in Medical Imaging1025.0%0.0%—
3Extracting Independent Prognostic Biomarkers from Medical Imagery1025.0%0.0%—
4Fusing Multi-Omics Data Across Biological Scales1025.0%0.0%—
5Overcoming Diagnostic Subjectivity with Computational Pathology1125.0%50.0%9
6Overcoming Sample Volume Constraints in Molecular Diagnostics1025.0%0.0%—
7Overcoming Tissue Sampling Bias via Quantitative Radiomics1025.0%0.0%—
8Quantifying Biological Heterogeneity Beyond Anatomical Staging1025.0%0.0%—
9The Clinical Data Granularity Gap in Population Registries1025.0%0.0%—
10Transcriptomic Deconvolution of Tissue Microenvironments1025.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Gastric 2023 papers: a paper credits every institution named in its affiliations, once. 7 institutions share 2 credited papers.

#InstitutionPapersShare20222022 rank
102h8a1848 150.0%0—
203cyvdv85 150.0%0—
305m1p5x56 150.0%0—
405pwsw714 150.0%0—
5Chinese University of Hong Kong 150.0%0—
6Hangzhou Normal University 150.0%0—
7Zhejiang University 150.0%0—

Download all institutions as CSV

About this data

Papers. Gastric 2023 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 2 to 4 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 4 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Gastric 2023”, https://lacuna.tiptreesystems.com/venue/gastric/2023.

Top Authors

AuthorPapers
Jakob Nikolas Kather1

Impactful Papers

Papers from Gastric 2023 that shaped research clusters.

Influential

Papers

Title
Correction: Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica
Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study
Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib